Selective vasopressin, angiotensin II, or dual receptor blockade with developing congestive heart failure.

Autor: J, Clair M, K, King M, T, Goldberg A, W, Hendrick J, R, Nisato, M, Gay D, E, Morrison A, H, McElmurray J, S, Krombach R, R, Bond B, C, Cazaubon, D, Nisato, G, Spinale F

Publikováno v: The Journal of Pharmacology and Experimental Therapeutics; June 2000, Vol. 293 Issue: 3 p852-60, 9p